Patient Guides
Evidence-based guides for international patients considering treatment in Shanghai.
-
GuideAlibaba's DAMO PANDA: First AI Model to Receive FDA 'Breakthrough Device' Status for Pancreatic Cancer Screening
Alibaba DAMO Academy's AI model can detect pancreatic cancer from routine CT scans with 92.9% sensitivity and 99.9% specificity — years before symptoms appear. Now FDA-recognized as a breakthrough medical device.
-
GuideA Brazilian Doctor Told Him: 'Go to Shanghai — That's Where the Best Surgeons Are'
How a Chinese-Brazilian patient flew 20,000 km from São Paulo to Ruijin Hospital for a robotic Whipple procedure — and why his Brazilian surgeon recommended it.
-
GuideChina's Global Leadership in Pancreatic Cancer: A 2024-2026 Deep Dive
From heavy ion therapy to robotic surgery to KRAS inhibitors — how China went from follower to leader in pancreatic cancer treatment. A comprehensive report on breakthroughs, survival rates, and next-generation drugs.
- Guide
Pancreatic Cancer Therapeutic Vaccines: Evidence Review of 7 Projects (2026)
Deep evidence grading of 7 pancreatic cancer vaccine projects — Neo-P DC, WT1 DC, PCNAT-01, P01, LK101, XH001, RGL-270. What the data actually shows vs. what's marketing.
-
GuideFrom Follower to Leader: Ruijin Hospital Achieves 21.2% Five-Year Survival in Pancreatic Cancer
How Ruijin Hospital's Pancreatic Disease Center became a global benchmark — 30,000+ cases treated, 21.2% 5-year survival (vs 9-12% global average), 4,000+ robotic surgeries, and China's first voice in the ESMO Asia-Pacific Consensus.
-
GuidePancreatic Cancer Surgery in Shanghai: What International Patients Need to Know
A disease-focused guide to hepatobiliary-pancreatic oncology in Shanghai — hospitals, surgeons, techniques, and what the data actually says.
-
GuideUK Patient Waited 6 Months — Flew to Shanghai, Had Surgery in 2 Weeks
How China's visa-free policy is opening a door for pancreatic cancer patients who can't afford to wait — or to pay.
-
GuideChina's 30-Day Visa-Free Policy Made Pancreatic Cancer Surgery Abroad Feasible
A realistic breakdown of costs, wait times, and logistics for patients considering hepatobiliary-pancreatic surgery in Shanghai.